E. Anders Kolb, MD, breaks down a new way to measure how blood cancer treatment advances translate into years of life saved.
E. Anders Kolb, MD
Advertisement
E. Anders Kolb, MD, is the president and CEO of Blood Cancer United.
Articles by E. Anders Kolb, MD
Advertisement
Latest Updated Articles
Dr Kolb on a Novel Methodology to Measure Progress in Blood CancersSeptember 4th 2026
Advertisement
Advertisement
Trending on OncLive
1
Five Under 5: Top Oncology Videos for the Week of 8/31/26
2
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
3
Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC
4
CARiBOU Regimen Drives Complete Metabolic Responses in First-Line Mantle Cell Lymphoma
5